A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with p (Q45216680)

From Wikidata
Jump to navigation Jump to search
scientific article published in November 2004
edit
Language Label Description Also known as
English
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with p
scientific article published in November 2004

    Statements

    A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with p (English)
    Harold E Bays
    Leiv Ose
    Neil Fraser
    Diane L Tribble
    Katherine Quinto
    Robert Reyes
    Amy O Johnson-Levonas
    Aditi Sapre
    Steven R Donahue
    Ezetimibe Study Group
    1 November 2004
    1758-1773

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit